Android app on Google Play

UPDATE: Traders Eye Nu Skin (NUS) Ahead of Bull/Bear Debate on CNBC

August 9, 2012 1:42 PM EDT Send to a Friend
(Updated - August 9, 2012 3:08 PM EDT)

(Video Added) Traders are watching Nu Skin Enterprises Inc. (NYSE: NUS) ahead of a CNBC's StreetSigns debate on the stock between short seller Andrew Left of Citron Research and Deutsche Bank's Bill Schmitz, a bull on the stock.

Shares of NUS have been under pressure this week after Citron issued a negative report on the company and the way it operates in China. According to the Citron, the company is operating illegally and China could shut them down.

"Nu Skin investors are exposed to the massive risk of its China operations coming to an abrupt halt due to violation of the PRC’s and Hong Kong pyramid sales laws. The consequences would be devastating," Citron states.

CNBC's StreetSigns starts at 2PM ET.

Shares of NUS are up 3.2 percent into the debate, after giving up 9 percent on Tuesday and another 5 percent on Wednesday, following the negative report.

VIDEO





You May Also Be Interested In


Related Categories

Trader Talk

Related Entities

Deutsche Bank, Citron Research

Add Your Comment